ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

PCSA Processa Pharmaceuticals Inc

2.14
-0.12 (-5.31%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Processa Pharmaceuticals Inc PCSA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.12 -5.31% 2.14 09:00:00
개장가 저가 고가 종가 전일 종가
2.30 2.15 2.30 2.17 2.26
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202421:00GLOBEProcessa Pharmaceuticals Names Dr. Steven Cha Senior Vice..
11/04/202421:00GLOBEProcessa Pharmaceuticals Presents Two Abstracts at the AACR..
28/03/202421:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest Biotech..
25/03/202421:15GLOBEProcessa Pharmaceuticals to Present Data at the American..
22/02/202407:25EDGAR2Form 8-K - Current report
21/02/202422:15GLOBEProcessa Pharmaceuticals to Present at the 2024 BIO CEO &..
15/02/202403:00GLOBEProcessa Pharmaceuticals to Present at The Winter Wrap-Up..
06/02/202422:30EDGAR2Form 8-K - Current report
06/02/202422:30GLOBEProcessa Pharmaceuticals Regains Compliance with Nasdaq..
02/02/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202406:22GLOBEProcessa Pharmaceuticals Announces Closing of $7.0 Million..
01/02/202406:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202400:46EDGAR2Form 8-K - Current report
30/01/202406:15EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
29/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
26/01/202423:04GLOBEProcessa Pharmaceuticals Announces Pricing of $7.0 Million..
25/01/202422:35EDGAR2Form 8-K - Current report
25/01/202422:30GLOBEProcessa Pharmaceuticals Announces Successful Completion of..
19/01/202422:00EDGAR2Form 8-K - Current report
19/01/202421:45GLOBEProcessa Pharmaceuticals Announces Expansion of NGC-Cap..
18/01/202422:30EDGAR2Form 8-K - Current report
18/01/202421:45GLOBEProcessa Pharmaceuticals to Effect a 1-for-20 Reverse Stock..
09/01/202406:30EDGAR2Form 8-K - Current report
03/01/202407:06GLOBEProcessa Pharmaceuticals to Present at the Biotech Showcase..
29/12/202322:55EDGAR2Form S-1 - General form for registration of securities under..
19/12/202323:00EDGAR2Form 8-K - Current report
19/12/202323:00GLOBEProcessa Pharmaceuticals Provides Interim Analysis from..
13/12/202323:00GLOBEProcessa Pharmaceuticals Announces Successful Phase 2..
06/12/202307:18EDGAR2Form 8-K - Current report
30/11/202322:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest..
29/11/202322:15GLOBEProcessa Pharmaceuticals Issues Letter to Shareholders..
17/11/202305:10EDGAR2Form 8-K - Current report
16/11/202301:30EDGAR2Form 8-K - Current report
14/11/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202304:45EDGAR2Form 8-K - Current report
14/11/202303:40GLOBEProcessa Pharmaceuticals, Inc. Mourns the Sudden Passing of..
09/11/202322:15GLOBEProcessa Pharmaceuticals to Present at the 20th Orphan Drugs..
01/11/202321:15GLOBEProcessa Pharmaceuticals Announces Formation of Oncology..
16/10/202322:15EDGAR2Form 8-K - Current report
14/10/202302:08GLOBEProcessa Pharmaceuticals to Present at the ThinkEquity..
13/10/202307:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202307:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202307:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202306:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202305:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202305:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202323:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/10/202323:00EDGAR2Form DEF 14A - Other definitive proxy statements

최근 히스토리

Delayed Upgrade Clock